Advanced search
Start date
Betweenand

Methylation profiles of hMLH1 and RASSF1 genes and proteomic analysis in bladder cancer cell lines submitted to treatments with the antineoplastic drugs cisplatin and gemcitabine

Grant number: 08/09147-6
Support type:Regular Research Grants
Duration: February 01, 2009 - January 31, 2012
Field of knowledge:Biological Sciences - Genetics - Mutagenesis
Principal researcher:Daisy Maria Favero Salvadori
Grantee:Daisy Maria Favero Salvadori
Home Institution: Faculdade de Medicina (FMB). Universidade Estadual Paulista (UNESP). Campus de Botucatu. Botucatu , SP, Brazil
Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
DA SILVA, GLENDA NICIOLI; FILONI, LEANDRO TOSHIO; SALVADORI, MARIA CECILIA; FAVERO SALVADORI, DAISY MARIA. Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation. Pathology & Oncology Research, v. 24, n. 2, p. 407-417, . (08/09147-6)
DE OLIVEIRA, DAIANE TEIXEIRA; VENTURA SAVIO, ANDRE LUIZ; DE CASTRO MARCONDES, JOAO PAULO; BARROS, TATIANE MARTINS; BARBOSA, LUDMILA CORREIA; FAVERO SALVADORI, DAISY MARIA; DA SILVA, GLENDA NICIOLI. Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status. JOURNAL OF BIOSCIENCES, v. 42, n. 1, p. 91-101, . (08/09147-6)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.